causal

US market subsidizes global drug innovation

Because U.S. prices are unrestrained while other countries negotiate lower prices, the United States acts as a cash cow whose market profitability drives pharmaceutical innovation for the whole world, and the high entry and compliance barriers prevent the new competitors that high profits would normally attract.

causalpending

Speaker

Russ Roberts

Evidence Quote

“the United States as this great cash cow, for pharma, is driving innovation for the whole world”

Source

Vincent Rajkumar on the High Price of Cancer Drugs— EconTalk
Created: 6/13/2026, 12:13:30 AM

Your notes

Loading notes...